Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: A 4-year retrospective, longitudinal study

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 12, 2011, Pages

  Seo, Mi Hae ^a   Bae, Ji Cheol ^b   Park, Se Eun ^a   Rhee, Eun Jung ^a   Park, Cheol Young ^a   Oh, Ki Won ^a   Park, Sung Woo ^a   Kim, Sun Woo ^a   Lee, Won Young ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; KOREAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; LIPIDS; LIPOPROTEINS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 83155177112     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1857     Document Type: Article

References (17)

1. Goldberg IJ 2001 Clinical review 124: diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 86:965-971 (Pubitemid 32322966)
2. von Eckardstein A, Schulte H, Assmann G 2000 Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Munster. J Clin Endocrinol Metab 85:3101-3108
3. Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Wolever TM, Hegele RA, Zinman B, Hanley AJ 2010 Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population. Clin Chem 56:666-670
4. Onat A, Can G, Hergenc G, Yazici M, Karabulut A, Albayrak S 2007 Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Int J Obes (Lond) 31:1119-1125 (Pubitemid 46987762)
5. Fryirs MA, Barter PJ, Appavoo M, Tuch BE, Tabet F, Heather AK, Rye KA 2010 Effects of high-density lipoproteins on pancreatic β-cell insulin secretion. Arterioscler Thromb Vasc Biol 30:1642-1648
6. 2010 Standards of medical care in diabetes - 2010. Diabetes Care 33(Suppl 1):S11-S61
7. Himmelmann A, Kjeldsen SE, Hedner T 2003 Recent hypertension guidelines: JNC-7 and 2003 ESH/ESC. Blood Press 12:196-197 (Pubitemid 37265349)
8. DeLong ER, DeLong DM, Clarke-Pearson DL 1988 Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845
9. Adiels M, Olofsson SO, Taskinen MR, Borén J 2008 Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28:1225-1236
10. Albers JJ, Marcovina SM, Imperatore G, Snively BM, Stafford J, Fujimoto WY, Mayer-Davis EJ, Petitti DB, Pihoker C, Dolan L, Dabelea DM 2008 Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes. J Clin Endocrinol Metab 93:735-742 (Pubitemid 351398547)
11. Haffner SM, Mykkänen L, Festa A, Burke JP, Stern MP 2000 Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 101:975-980 (Pubitemid 30131698)
12. Hao M, Head WS, Gunawardana SC, Hasty AH, Piston DW 2007 Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic β-cell dysfunction. Diabetes 56:2328-2338 (Pubitemid 47358240)
13. Brunham LR, Kruit JK, Verchere CB, Hayden MR 2008 Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest 118:403-408 (Pubitemid 351206525)
14. Kruit JK, Brunham LR, Verchere CB, Hayden MR 2010 HDL and LDL cholesterol significantly influence β-cell function in type 2 diabetes mellitus. Curr Opin Lipidol 21:178-185
15. Arsenault BJ, Boekholdt SM, Kastelein JJ 2011 Lipid parameters for measuring risk of cardiovascular disease. Nat Rev Cardiol 8:197-206
16. Irving BA, Nair KS, Srinivasan M 2011 Effects of insulin sensitivity, body composition, and fitness on lipoprotein particle sizes and concentrations determined by nuclear magnetic resonance. J Clin Endocrinol Metab 96:E713-E718
17. Barter PJ 2011 The causes and consequences of low levels of high density lipoproteins in patients with diabetes. Diabetes Metab J 35:101-106